Drugs for GI infections II Flashcards
MOA bismuth subsalicaylate
bismuth coats ulcers and erosions forming protective barrier
atimulates PG, mucus, and HCO3
salicylate inhibites intestinal PG and Cl secretion (reduce stool frequency and liquidity in infecitous diarrhea)
therapeutic use bismuth subsalicylate
dyspepsia and acute diarrhea
travelers diarrhea
H pylor infection
adverse reactions from bismuth subsalicylate
harmless blackening of stool, liwuid could cause blackening of tongue
high doses: slaicylate toxicity, Reyes syndrome in kids
avoid in renal impairment
MOA fluoroquinolones
[ ] dep killing
targets bacterial DNA gyrase and topoisomerase IV
bacterial R to fluoroquinolones
mutation in bacterial chromosome genes encoding DNA gyrase or topoisomerase IV or by active trasnport out of the cell
fluoroquinolones work on what bacteria
E coli, salmonella, shigella, enterobacter, campylobacter, neisseria, pseudomonas, aeruginosa, S aureus
which fluoroquinolones work on strep spp
levofloxacin, gatifloxacin and moxifloxacin
therapeutic uses of fluoroquinolones
UTI, prostatisi, STI, travelers diarrhea, shigellosis, joint STTI infeciotns, DM foot infections
adverse effects fluoroquinolones
GI (nausea, vomiting, abdominal discomfort)
CNS(mild HA, dizziness, delirium, rare hallucinations)
rash, photosensitivity, Achilles tendon rupture
contraindications to fluoroquinolones
children because of achilles tendon rupture
MOA aminoglycosides
[ ] dependent, binds 30s ribosomeal subunit and disrupts normal cycle ribosomal funciton by interfering with initiation protein synthesis
bacterial R to aminoglycosides
AG metabolizing enzymes, impaired transport of drug into cell, altered ribosom
what microbesn are aminoglycosdes used against
aerobic gram - bacteria, limited action against gram +, produces synergistic bactericidal effects in gram + when combine with a cell wall active agent
GI uses aminoglycosides
UTI, peritonitis with peritoneal dialysis
adverse effects aminoglycosdes
ototoxicity, nephrotoxicity, neuromuscular block and apnea
what are the aminoglycosides
amikacin
tobramycin
gentamicin
MOA tetracycline
bacteriostatic, inhibits bacterial protein synthesis by binding 30s bacterial ribosome and preventing access of aminoacyl tRNA to acceptro A site on mRNA ribosome complex
bacterial R to tetracyline
decreased influx acquisition of energy dependent efflux, ribosomal protection proteins, enzymatic inactivation